Form 4 for CDNA CareDx, Inc.
Accepted 2023-02-03 00:00:00 ET · period of report 2023-02-01 · accession 0001217234-23-000027 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-03 | 2023-02-01 | CDNA | Maag Peter | Dir | A - Grant | $0.00 | +5,230 | 303.7K | +2% | $0 | |
| 2023-02-03 | 2023-02-02 | CDNA | Maag Peter | Dir | S - Sale | $17.17 | -5,000 | 298.7K | -2% | -$85.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-01 | A | A | 5,230 | $0.00 | 303,737 | D | — | — | (F1) The reported securities were subject to a performance restricted stock unit award that was initially granted on February 3, 2021 for a two-year performance period over calendar years 2021 and 2022, which performance was assessed and finalized effective February 1, 2023. 50.00% of the reported securities vested on February 1, 2023 and 50% of the reported securities will vest on December 31, 2023, subject to the Reporting Person's continued service with the Issuer. |
| 2 | Common | Common Stock | 2023-02-02 | S | D | 5,000 | $17.17 | 298,737 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.08 to $17.285, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. |